Theseus Pharmaceuticals, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Theseus Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q3 2023.
  • Theseus Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$13.5M, a 8.42% increase year-over-year.
  • Theseus Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$56.6M, a 24.3% decline year-over-year.
  • Theseus Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$50.6M, a 85.3% decline from 2021.
  • Theseus Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$27.3M, a 128% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$56.6M -$13.5M +$1.24M +8.42% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-17
Q2 2023 -$57.9M -$14.8M -$3.16M -27.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-17
Q1 2023 -$54.7M -$14.6M -$4.09M -39% Jan 1, 2023 Mar 31, 2023 10-Q 2023-11-17
Q4 2022 -$50.6M -$13.7M -$5.06M -58.5% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-09
Q3 2022 -$45.5M -$14.7M -$7.37M -100% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-17
Q2 2022 -$38.2M -$11.6M -$4.84M -71.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-17
Q1 2022 -$33.3M -$10.5M -$6.02M -135% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-17
Q4 2021 -$27.3M -$8.66M -$5.77M -200% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 -$21.5M -$7.37M -$5.94M -416% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$15.6M -$6.81M -$1.39M -25.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-03
Q1 2021 -$14.2M -$4.47M -$2.21M -97.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-03
Q4 2020 -$12M -$2.89M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 -$1.43M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$5.41M Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$2.27M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.